Roger Schibli
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Haider A, Pacher P, Herde A, Spinelli F, Ahmed H, Atz K, Keller C, Weber M, Schibli R, Mu L, Grether U, Knuesel I, Bartelmus C, Gobbi L, Kretz J, Ullmer C, Brink A, Honer M, Woltering T, Muri D, Iding H, Bürkler M, Binder M, Ametamey S. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J Med Chem 2020; 63:10287-10306.
01.09.2020Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
01.09.2020J Med Chem 2020; 63:10287-10306
Haider Ahmed, Pacher Pal, Herde Adrienne Müller, Spinelli Francesco, Ahmed Hazem, Atz Kenneth, Keller Claudia, Weber Markus, Schibli Roger, Mu Linjing, Grether Uwe, Knuesel Irene, Bartelmus Christian, Gobbi Luca, Kretz Julian, Ullmer Christoph, Brink Andreas, Honer Michael, Woltering Thomas J, Muri Dieter, Iding Hans, Bürkler Markus, Binder Martin, Ametamey Simon M
Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Gnesin S, Prior J, Treyer V, Kaufmann P, Ametamey S, Schibli R, Müller C, Choschzick M, Früh M, Siano M, Meisel A, Burger I, Müller J, Schaefer N. Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI Res 2020; 10:32.
08.04.2020Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
08.04.2020EJNMMI Res 2020; 10:32
Gnesin Silvano, Prior John O, Treyer Valerie, Kaufmann Philipp A, Ametamey Simon M, Schibli Roger, Müller Cristina, Choschzick Matthias, Früh Martin, Siano Marco, Meisel Alexander, Burger Irene A, Müller Joachim, Schaefer Niklaus
First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands
Rupp N, Schibli R, Eberli D, Huber G, Morand G, Messerli M, Ferraro D, Mühlematter U, Müller J, Töpfer A, Lenggenhager D, Pizzuto D, Umbricht C, Burger I. First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands. J Nucl Med 2019
08.02.2019First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands
08.02.2019J Nucl Med 2019
Rupp Niels J, Schibli Roger, Eberli Daniel, Huber Gerhard, Morand Grégoire B, Messerli Michael, Ferraro Daniela A, Mühlematter Urs Jacob, Müller Julian, Töpfer Antonia, Lenggenhager Daniela, Pizzuto Daniele A, Umbricht Christoph A, Burger Irene A
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
Müller Herde A, Schibli R, Weber M, Ametamey S. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients. Eur J Nucl Med Mol Imaging 2018
05.10.2018Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
05.10.2018Eur J Nucl Med Mol Imaging 2018
Müller Herde Adrienne, Schibli Roger, Weber Markus, Ametamey Simon M
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Slavik R, Müller Herde A, Haider A, Krämer S, Weber M, Schibli R, Ametamey S, Mu L. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. J Neurochem 2016; 138:874-86.
02.08.2016Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
02.08.2016J Neurochem 2016; 138:874-86
Slavik Roger, Müller Herde Adrienne, Haider Ahmed, Krämer Stefanie D, Weber Markus, Schibli Roger, Ametamey Simon M, Mu Linjing
Evaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkers
Jodal A, Pape F, Becker-Pauly C, Maas O, Schibli R, Béhé M. Evaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkers. PloS one 2015; 10:e0123443.
09.04.2015Evaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkers
09.04.2015PloS one 2015; 10:e0123443
Jodal Andreas, Pape Fabienne, Becker-Pauly Christoph, Maas Ole, Schibli Roger, Béhé Martin
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
Mu L, Slavik R, Müller A, Popaj K, Cermak S, Weber M, Schibli R, Krämer S, Ametamey S. Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor. Pharmaceuticals (Basel) 2014; 7:339-52.
06.03.2014Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
06.03.2014Pharmaceuticals (Basel) 2014; 7:339-52
Mu Linjing, Slavik Roger, Müller Adrienne, Popaj Kasim, Cermak Stjepko, Weber Markus, Schibli Roger, Krämer Stefanie D, Ametamey Simon M
Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain
Slavik R, Bieri D, Cermak S, Müller A, Krämer S, Weber M, Schibli R, Ametamey S, Mu L. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain. Chimia (Aarau) 2014; 68:208-10.
01.01.2014Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain
01.01.2014Chimia (Aarau) 2014; 68:208-10
Slavik Roger, Bieri Daniel, Cermak Stjepko, Müller Adrienne, Krämer Stefanie D, Weber Markus, Schibli Roger, Ametamey Simon M, Mu Linjing
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Mu L, Krämer S, Schibli R, Weber M, Cermak S, Müller A, Drandarov K, Slavik R, Bieri D, Ametamey S. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. J Neurochem 2013; 126:616-24.
19.07.2013Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
19.07.2013J Neurochem 2013; 126:616-24
Mu Linjing, Krämer Stefanie D, Schibli Roger, Weber Markus, Cermak Stjepko, Müller Adrienne, Drandarov Konstantin, Slavik Roger, Bieri Daniel, Ametamey Simon M
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate
Müller C, Forrer F, Schibli R, Krenning E, de Jong M. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. J Nucl Med 2008; 49:310-7.
16.01.2008SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate
16.01.2008J Nucl Med 2008; 49:310-7
Müller Cristina, Forrer Flavio, Schibli Roger, Krenning Eric P, de Jong Marion
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys
Müller C, Schibli R, Forrer F, Krenning E, de Jong M. Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys. Nucl Med Biol 2007; 34:603-8.
01.08.2007Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys
01.08.2007Nucl Med Biol 2007; 34:603-8
Müller Cristina, Schibli Roger, Forrer Flavio, Krenning Eric P, de Jong Marion